While the threat of U.S. import tariffs prompted a surge in drug production last year, that output is slated to slow across multiple geographies in 2026. | While the threat of U.S. import tariffs ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's ...

WENZHOU, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- As the global pharmaceutical and healthcare ...

HANGZHOU CITY, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- With the development of the pharmaceutical and ...

For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing ...

PMMI research identifies top manufacturing hurdles including regulatory compliance, automation needs, and sustainability priorities ...

By Leah Douglas WASHINGTON, Jan 30 (Reuters) - Eli Lilly announced on Friday that it will build a pharmaceutical ...

At long last, the Trump administration’s much-ballyhooed tariffs on pharmaceutical imports are materializing in a trade deal with the European Union. Still, as with previous communications on the ...

The FDA launched PreCheck pilot program to strengthen U.S. drug supply chain by improving regulatory predictability.

Automation and AI are revolutionizing the pharmaceutical industry, optimizing technical development and enabling faster, more ...

The CDMO Sector Holds a Core Position in the Pharmaceutical Industry As a major part of the outsourcing pharmaceutical service industry, CDMOs support pharmaceutical companies across the entire chain, ...